FS
Financial Symmetry Inc
13F filer · CIK 0002004843Reported Jul 14, 2026
Net buyer this quarter
13F portfolio value$300MU.S. long equity reported on 13F
Positions336 new · 0 closed
Net flow last quarter+$4.88MBuys minus sells
Top 10 positions weight23.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 14, 202633 positions | |||||
| $59.1M | 19.71% | Not reported | +3.8% | Q4 2023 | |
| $3.62M | 1.21% | 0.00% | +4.2% | Q4 2023 | |
| $1.57M | 0.52% | 0.00% | +29.3% | Q1 2024 | |
| $1.1M | 0.37% | 0.00% | -2.4% | Q4 2023 | |
| $914K | 0.30% | 0.00% | +13.5% | Q4 2023 | |
| $822K | 0.27% | Not reported | +0.1% | Q1 2026 | |
| $820K | 0.27% | 0.00% | +2.2% | Q4 2023 | |
| $818K | 0.27% | 0.00% | +21.6% | Q4 2023 | |
| $733K | 0.24% | Not reported | +1.7% | Q2 2024 | |
| $592K | 0.20% | 0.00% | -2.4% | Q4 2023 | |
| $563K | 0.19% | 0.00% | +123.9% | Q4 2025 | |
| $501K | 0.17% | 0.00% | +7.6% | Q4 2023 | |
| $412K | 0.14% | 0.00% | +22.9% | Q2 2024 | |
| $410K | 0.14% | 0.00% | +17.1% | Q4 2025 | |
| $378K | 0.13% | 0.00% | Not reported | Q4 2023 | |
| DEDUKDuke Energy CORP | $372K | 0.12% | 0.00% | 0.0% | Q3 2025 |
| $299K | 0.10% | 0.00% | +6.9% | Q1 2025 | |
| $292K | 0.10% | 0.00% | +13.3% | Q1 2024 | |
| $270K | 0.09% | 0.00% | Not reported | Q1 2026 | |
| $269K | 0.09% | 0.00% | Not reported | Q4 2025 | |
| $261K | 0.09% | 0.00% | Not reported | Q4 2023 | |
| $250K | 0.08% | 0.00% | New | Q2 2026 | |
| $241K | 0.08% | 0.00% | Not reported | Q4 2023 | |
| $237K | 0.08% | 0.00% | New | Q2 2026 | |
| $233K | 0.08% | 0.00% | Not reported | Q1 2026 | |
| $229K | 0.08% | 0.00% | New | Q2 2026 | |
| $214K | 0.07% | 0.00% | +9.4% | Q3 2024 | |
| $209K | 0.07% | 0.00% | New | Q2 2026 | |
| $208K | 0.07% | Not reported | -1.8% | Q1 2026 | |
| $206K | 0.07% | 0.00% | +14.2% | Q1 2026 | |
| $201K | 0.07% | 0.00% | New | Q2 2026 | |
| $157K | 0.05% | 0.02% | Not reported | Q1 2024 | |
| PBPVCTProvectus Biopharmaceuticals, Inc. | $707 | 0.00% | 0.00% | Not reported | Q4 2023 |
| Q1 2026Reported May 11, 202627 positions | |||||
| $56.6M | 20.10% | Not reported | -0.8% | Q4 2023 | |
| $3.26M | 1.16% | 0.00% | -4.7% | Q4 2023 | |
| $1.21M | 0.43% | 0.00% | -11.6% | Q1 2024 | |
| $895K | 0.32% | 0.00% | +2.1% | Q4 2023 | |
| $875K | 0.31% | 0.00% | +1.0% | Q4 2023 | |
| $786K | 0.28% | Not reported | New | Q1 2026 | |
| $780K | 0.28% | Not reported | -0.1% | Q2 2024 | |
| $735K | 0.26% | 0.00% | -25.2% | Q4 2023 | |
| $728K | 0.26% | 0.00% | -1.1% | Q4 2023 | |
| $498K | 0.18% | 0.00% | -7.4% | Q4 2023 | |
| $421K | 0.15% | 0.00% | +0.9% | Q4 2023 | |
| DEDUKDuke Energy CORP | $381K | 0.14% | 0.00% | Not reported | Q3 2025 |
| $371K | 0.13% | 0.00% | +6.5% | Q2 2024 | |
| $326K | 0.12% | 0.00% | +1.7% | Q1 2025 | |
| $325K | 0.12% | 0.00% | +0.7% | Q4 2023 | |
| $283K | 0.10% | 0.00% | -5.9% | Q4 2023 | |
| $273K | 0.10% | 0.00% | -8.8% | Q4 2025 | |
| $248K | 0.09% | 0.00% | -2.6% | Q1 2024 | |
| $236K | 0.08% | 0.00% | Not reported | Q4 2023 | |
| $236K | 0.08% | 0.00% | New | Q1 2026 | |
| $222K | 0.08% | 0.00% | New | Q1 2026 | |
| $216K | 0.08% | 0.00% | +1.4% | Q3 2024 | |
| $211K | 0.08% | 0.00% | Not reported | Q4 2025 | |
| $204K | 0.07% | 0.00% | New | Q1 2026 | |
| $203K | 0.07% | Not reported | New | Q1 2026 | |
| $156K | 0.06% | 0.02% | Not reported | Q1 2024 | |
| PBPVCTProvectus Biopharmaceuticals, Inc. | $581 | 0.00% | 0.00% | Not reported | Q4 2023 |
| Q4 2025Reported Jan 28, 202625 positions | |||||
| $51M | 20.79% | Not reported | +2.2% | Q4 2023 | |
| $3.43M | 1.40% | 0.00% | -4.1% | Q4 2023 | |
| $1.28M | 0.52% | 0.00% | +0.3% | Q1 2024 | |
| $1.17M | 0.48% | 0.00% | +1.3% | Q4 2023 | |
| $868K | 0.35% | 0.00% | -5.5% | Q4 2023 | |
| $763K | 0.31% | 0.00% | -3.3% | Q4 2023 | |
| $729K | 0.30% | 0.00% | -14.5% | Q4 2023 | |
| $690K | 0.28% | 0.00% | +34.5% | Q4 2023 | |
| $641K | 0.26% | Not reported | +1.7% | Q2 2024 | |
| $376K | 0.15% | 0.00% | -2.8% | Q4 2023 | |
| DEDUKDuke Energy CORP | $345K | 0.14% | 0.00% | Not reported | Q3 2025 |
| $344K | 0.14% | 0.00% | New | Q4 2025 | |
| $342K | 0.14% | 0.00% | Not reported | Q4 2023 | |
| $317K | 0.13% | Not reported | Not reported | Q3 2024 | |
| $314K | 0.13% | 0.00% | -1.8% | Q4 2023 | |
| $289K | 0.12% | 0.00% | +4.6% | Q2 2024 | |
| $270K | 0.11% | 0.00% | -8.9% | Q1 2025 | |
| $270K | 0.11% | 0.00% | Not reported | Q1 2024 | |
| $268K | 0.11% | 0.00% | Not reported | Q4 2023 | |
| $257K | 0.10% | 0.00% | Not reported | Q3 2024 | |
| $228K | 0.09% | 0.00% | New | Q4 2025 | |
| $207K | 0.08% | 0.00% | -9.2% | Q2 2024 | |
| $202K | 0.08% | 0.00% | New | Q4 2025 | |
| $134K | 0.05% | 0.02% | Not reported | Q1 2024 | |
| PBPVCTProvectus Biopharmaceuticals, Inc. | $570 | 0.00% | 0.00% | Not reported | Q4 2023 |
| Q3 2025Reported Dec 17, 202522 positions | |||||
| $47.8M | 21.45% | Not reported | Not reported | Q4 2023 | |
| $3.35M | 1.50% | 0.00% | Not reported | Q4 2023 | |
| $1.27M | 0.57% | 0.00% | Not reported | Q1 2024 | |
| $1.23M | 0.55% | 0.00% | Not reported | Q4 2023 | |
| $908K | 0.41% | 0.00% | Not reported | Q4 2023 | |
| $758K | 0.34% | 0.00% | Not reported | Q4 2023 | |
| $751K | 0.34% | 0.00% | Not reported | Q4 2023 | |
| $489K | 0.22% | Not reported | Not reported | Q2 2024 | |
| $489K | 0.22% | 0.00% | Not reported | Q4 2023 | |
| $370K | 0.17% | 0.00% | Not reported | Q3 2024 | |
| DEDUKDuke Energy CORP | $364K | 0.16% | 0.00% | New | Q3 2025 |
| $346K | 0.16% | 0.00% | Not reported | Q4 2023 | |
| $318K | 0.14% | 0.00% | Not reported | Q4 2023 | |
| $296K | 0.13% | 0.00% | Not reported | Q4 2023 | |
| $275K | 0.12% | 0.00% | Not reported | Q1 2025 | |
| $267K | 0.12% | 0.00% | Not reported | Q4 2023 | |
| $263K | 0.12% | 0.00% | Not reported | Q1 2024 | |
| $263K | 0.12% | 0.00% | Not reported | Q2 2024 | |
| $244K | 0.11% | 0.00% | Not reported | Q2 2024 | |
| $177K | 0.08% | 0.02% | Not reported | Q1 2024 | |
| PBPVCTProvectus Biopharmaceuticals, Inc. | $907 | 0.00% | 0.00% | Not reported | Q4 2023 |
| PAPTAMPotash America, Inc. | $26 | 0.00% | Not reported | New | Q3 2025 |
Premium opens every quarter this fund has filed